Analytical Services

Delivering Reliable Data That Drives Confident Drug Development

Corealis Pharma provides comprehensive analytical development and testing services that support every stage of oral solid dose development. From early method development to GMP release and stability testing, our analytical teams generate the critical data needed to guide formulation decisions, ensure product quality, and support regulatory requirments.

Our integrated approach ensures analytical methods evolve alongside your program, providing reliable, phase-appropriate data from development through clinical manufacturing.

Building the Analytical Foundation for Development and Manufacturing

Analytical development is essential to understanding and controlling drug product quality. At Corealis, we design and implement analytical methods that characterize APIs and drug products, monitor stability, and ensure consistency throughout development and manufacturing. 

Our teams provide the data required to support formulation optimization, GMP manufacturing, and regulatory submissions, ensuring your program progresses with confidence.

Our Analytical Development Workflow

  1. Method Transfer & Evaluation

    We transfer and assess existing analytical methods from the client, ensuring suitability for development and GMP environments.


  2. Method Development & Optimization

    Analytical methods are developed or refined to support API characterization and drug product evaluation.


  3. Validation & Qualification

    Phase-appropriate validation ensures methods meet regulatory expectations and are suitable for GMP use.


  4. GMP Testing & Stability Programs

    We perform release testing, stability studies, and ongoing analytical support throughout clinical development.

Technical Capabilities

Analytical Method Development

  • Assay and potency methods 

  • Impurity and related substances analysis 

  • Content and blend uniformity 

  • Dissolution testing (UV, HPLC) 

  • Degradation product identification 

Stability & Stress Testing

  • Forced degradation studies 

  • Photostability testing 

  • Stability studies under ICH conditions 

  • Compatibility and stability studies supporting R&D 

API & Drug Product Testing

  • Solubility testing in biorelevant media 

  • Physicochemical characterization 

  • Release testing for APIs and drug products 

GMP Analytical Services

  • cGMP release testing of APIs and drug products 

  • Testing of excipients and packaging materials 

  • Stability storage and testing programs 

  • Cleaning verification methods and testing 

  • Analytical method transfer to client or partner laboratories

These capabilities provide the analytical data required to support formulation development, manufacturing, and regulatory readiness.

Typical Timeline

From Molecule to Clinical Supply

A structured development pathway designed to accelerate oral solid dose programs from early formulation to GMP clinical manufacturing. While timelines vary depending on API complexity and formulation strategy, a typical development pathway may include:


  • Pre-Formulation & Method Evaluation:

    • 1-2 weeks

  • Prototype Development 5-8 Prototypes:

    • 4-5 weeks

  • Engineering Batch:

    • 2-3 weeks

  • GMP Batch Preparation & Planning:

    • 2 weeks

  • GMP Manufacturing, Release and QA Review:

    • 6 weeks

  • Report:

    • 4-6 weeks

Typical duration:
4–6 months or less.

*Timelines may vary depending on program complexity and development strategy.

Key Analytical Instrumentation

Corealis leverages advanced analytical technologies to ensure accurate and reliable data generation.

Representative instruments include:

  • UPLC / HPLC systems 

  • Gas chromatography (GC) 

  • Dissolution testing systems 

  • UV spectrophotometry 

  • Karl Fischer titration systems 

  • ICP-OES for elemental analysis 

  • Stability chambers (ICH conditions) 

  • Wet chemistry and analytical support tools 

These instruments enable comprehensive characterization, testing, and quality control of APIs and drug products.

See Our Development Facilities

Corealis operates more than 60,000 square feet of integrated formulation, analytical, and GMP manufacturing facilities located in Laval, Canada.

Visiting our laboratories provides an opportunity to meet the scientists supporting your program and see firsthand how our teams collaborate to solve complex formulation challenges.

FAQ

What is the role of analytical development in drug development?

Do you support both API and drug product testing?

Can Corealis transfer existing analytical methods?

What types of analytical methods do you develop?

Do you provide GMP analytical testing?

How long does analytical method development take?

Learn more how Corealis can support your drug product development needs.